|
1
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yagoda A, Abi-Rached B and Petrylak D:
Chemotherapy for advanced renal-cell carcinoma: 1983–1993. Semin
Oncol. 22:42–60. 1995.
|
|
3
|
Li L, Gao Y, Zhang L, Zeng J, He D and Sun
Y: Silibinin inhibits cell growth and induces apoptosis by caspase
activation, down-regulating survivin and blocking EGFR-ERK
activation in renal cell carcinoma. Cancer Lett. 272:61–69. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bex A, Kerst M, Mallo H, Meinhardt W,
Horenblas S and de Gast GC: Interferon alpha 2b as medical
selection for nephrectomy in patients with synchronous metastatic
renal cell carcinoma: a consecutive study. Eur Urol. 49:76–81.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calderón-Montaño JM, Burgos-Morón E,
Pérez-Guerrero C and López-Lázaro M: A review on the dietary
flavonoid kaempferol. Mini Rev Med Chem. 11:298–344.
2011.PubMed/NCBI
|
|
6
|
Cui Y, Morgenstern H, Greenland S, et al:
Dietary flavonoid intake and lung cancer - a population-based
case-control study. Cancer. 112:2241–2248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nothlings U, Murphy SP, Wilkens LR,
Henderson BE and Kolonel LN: Flavonols and pancreatic cancer risk:
the multiethnic cohort study. Am J Epidemiol. 166:924–931. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gates MA, Tworoger SS, Hecht JL, De Vivo
I, Rosner B and Hankinson SE: A prospective study of dietary
flavonoid intake and incidence of epithelial ovarian cancer. Int J
Cancer. 121:2225–2232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo H, Daddysman MK, Rankin GO, Jiang BH
and Chen YC: Kaempferol enhances cisplatin’s effect on ovarian
cancer cells through promoting apoptosis caused by down regulation
of cMyc. Cancer Cell Int. 10:162010.PubMed/NCBI
|
|
10
|
Kang JW, Kim JH, Song K, Kim SH, Yoon JH
and Kim KS: Kaempferol and Kaempferol and quercetin, components of
Ginkgo biloba extract (EGb 761), induce caspase-3-dependent
apoptosis in oral cavity cancer cells. Phytother Res. 24(Suppl 1):
S77–S82. 2010.PubMed/NCBI
|
|
11
|
Huang WW, Chiu YJ, Fan MJ, et al:
Kaempferol induced apoptosis via endoplasmic reticulum stress and
mitochondria-dependent pathway in human osteosarcoma U-2 OS cells.
Mol Nutr Food Res. 54:1585–1595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Du B, Wang T, Wang S and Zhang J:
Kaempferol induces apoptosis in human HCT116 colon cancer cells via
the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement
of p53 Upregulated Modulator of Apoptosis. Chem Biol Interact.
177:121–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin W, Lei Y-H, Su M, Li D-J, Zhang N and
Shen Y-Q: Kaempferol inhibits proliferation of human prostate
cancer PC-3 cells via down-regulation of PCNA and VCAM-1. Zhongguo
Yaolixue Tongbao. 27:553–557. 2011.(In Chinese).
|
|
14
|
Ahn MR, Kunimasa K, Kumazawa S, et al:
Correlation between antiangiogenic activity and antioxidant
activity of various components from propolis. Mol Nutr Food Res.
53:643–651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schindler R and Mentlein R: Flavonoids and
vitamin E reduce the release of the angiogenic peptide vascular
endothelial growth factor from human tumor cells. J Nutr.
136:1477–1482. 2006.PubMed/NCBI
|
|
16
|
Shin MS, Shinghirunnusorn P, Sugishima Y,
et al: Cross interference with TNF-alpha-induced TAK1 activation
via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1.
Biochim Biophys Acta. 1793:1156–1164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cohen D, Lane B, Jin T, et al: The
prognostic significance of epidermal growth factor receptor
expression in clear-cell renal cell carcinoma: a call for
standardized methods for immunohistochemical evaluation. Clin
Genitourin Cancer. 5:264–270. 2007. View Article : Google Scholar
|
|
18
|
Badalian G, Derecskei K, Szendroi A,
Szendroi M and Timar J: EGFR and VEGFR2 protein expressions in bone
metastases of clear cell renal cancer. Anticancer Res. 27:889–894.
2007.PubMed/NCBI
|
|
19
|
Fanger GR, Johnson NL and Johnson GL: MEK
kinases are regulated by EGF and selectively interact with
Rac/Cdc42. EMBO J. 16:4961–4972. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marshall CJ: Specificity of receptor
tyrosine kinase signaling: transient versus sustained extracellular
signal-regulated kinase activation. Cell. 80:179–185. 1995.
View Article : Google Scholar
|
|
21
|
Han Y, Caday CG, Nanda A, Cavenee WK and
Huang HJ: Tyrphostin AG 1478 preferentially inhibits human glioma
cells expressing truncated rather than wild-type epidermal growth
factor receptors. Cancer Res. 56:3859–3861. 1996.PubMed/NCBI
|
|
22
|
Clerk A and Sugden PH: The p38-MAPK
inhibitor, SB203580, inhibits cardiac stress-activated protein
kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett.
426:93–96. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Labbe D, Provencal M, Lamy S, Boivin D,
Gingras D and Beliveau R: The flavonols quercetin, kaempferol, and
myricetin inhibit hepatocyte growth factor-induced medulloblastoma
cell migration. J Nutr. 139:646–652. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nguyen TTT, Tran E, Ong CK, et al:
Kaempferol-induced growth inhibition and apoptosis in A549 lung
cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol.
197:110–121. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang WW, Tsai SC, Peng SF, et al:
Kaempferol induces autophagy through AMPK and AKT signaling
molecules and causes G2/M arrest via downregulation of
CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells. Int J Oncol.
42:2069–2077. 2013.PubMed/NCBI
|
|
27
|
Naowaratwattana W, De-Eknamkul W and De
Mejia EG: Phenolic-containing organic extracts of mulberry
(Morus alba L.) leaves inhibit HepG2 hepatoma cells through
G2/M phase arrest, induction of apoptosis, and inhibition of
topoisomerase IIα activity. J Med Food. 13:1045–1056.
2010.PubMed/NCBI
|
|
28
|
Zhang Q, Zhao XH and Wang ZJ: Cytotoxicity
of flavones and flavonols to a human esophageal squamous cell
carcinoma cell line (KYSE-510) by induction of G2/M arrest and
apoptosis. Toxicol In Vitro. 23:797–807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mu JJ, Zeng YY, Huang XY, Zhao XH and Song
B: Effects of Kaempferol on activation, proliferation and cell
cycle of mouse T lymphocytes in vitro. Xi Bao Yu Fen Zi Mian Yi Xue
Za Zhi. 25:1106–1108. 2009.(In Chinese).
|
|
30
|
Eto M and Naito S: Molecular targeting
therapy for renal cell carcinoma. Int J Clin Oncol. 11:209–213.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Staehler M, Rohrmann K, Haseke N, Stief CG
and Siebels M: Targeted agents for the treatment of advanced renal
cell carcinoma. Curr Drug Targets. 6:835–846. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang LJ, Chen S, Wu P, et al: Inhibition
of MEK blocks GRP78 up-regulation and enhances apoptosis induced by
ER stress in gastric cancer cells. Cancer Lett. 274:40–46. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oda K, Matsuoka Y, Funahashi A and Kitano
H: A comprehensive pathway map of epidermal growth factor receptor
signaling. Mol Syst Biol. 1:2005.00102005.PubMed/NCBI
|
